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macrophage function and recruitment of T lymphocytes
to sites of plaque formation.3 Furthermore, there is evi-
dence that increased levels of antibodies to hsp60/65
occur in patients with carotid artery atherosclerosis, sug-
gesting that a humoral immune response to hsps may play
a significant role in atherogenesis.4
We recently cloned and characterized a novel 46-kDa
hsp from human tissue, termed HDJ-2, which represents a
human homologue of the DNA-J hsp found in Escherichia
coli.5 Several studies have suggested that HDJ-2 may have
an immunogenic role in transplantation, because its expres-
sion is upregulated during allograft rejection.6,7 Given the
evidence that hsps such as hsp60 and hsp70 are involved in
the autoimmune response associated with atherosclerosis,
it is important to define the role of other hsps during the
development of the atherosclerotic plaque. No studies have
been carried out to determine the role of HDJ-2 in the
pathogenesis of atherosclerosis. Therefore, this study was
designed to determine whether there is a correlation
between the expression of HDJ-2 and the development of
atherosclerotic plaques and to identify the specific cell types
expressing HDJ-2 in the atherosclerotic lesion.
This study demonstrates that in situ HDJ-2 expression
is increased in the atherosclerotic carotid artery plaque to
a greater extent than hsp60 and hsp70. In addition, this
The pathologic condition of atherosclerotic lesions is
characterized by cellular infiltration, proliferation, and
lipid accumulation within the vessel wall, as well as depo-
sition of extracellular matrix, which results in luminal
stenosis or occlusion. In recent years, increasing evidence
has suggested that atherosclerosis is also associated with
features of autoimmunity.1 This immune response appears
to be associated with elevated tissue expression of heat
shock proteins (hsp), such as hsp60/65 and hsp70.1
Additional studies have demonstrated diverse roles for
hsps in atherogenesis, ranging from protection of
endothelial cells from stress2 to dysregulation of
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Purpose: Evidence suggests that both humoral and cellular autoimmune processes directed toward heat shock proteins
(hsp) contribute to the pathogenesis of atherosclerosis. We characterized a human hsp distinct from those previously
characterized in atherosclerotic lesions, termed HDJ-2.
Methods: To determine the role of HDJ-2 in atherosclerosis, we compared the level of HDJ-2 mRNA expression with
the level of hsp60 and hsp70 mRNA expression in 26 carotid endarterectomy specimens and 17 normal arteries. The
level of expression of HDJ-2 mRNA was also correlated to the presence of plaque ulceration and the degree of luminal
stenosis associated with the lesion. 
Results: The expression of HDJ-2 and hsp70 was significantly higher in carotid artery plaques as compared with nor-
mal arteries: HDJ-2, 6.7 ± 1.6 vs 0.1 ± 0.04, (P = .001); hsp70, 9.5 ± 0.9 vs 3.7 ± 0.8, (P = .002). There was no sig-
nificant difference in hsp60 expression between carotid artery plaques and normal arteries (21.0 ± 0.9 vs 20.6 ± 0.8,
P = .65). Increased HDJ-2 expression in carotid artery plaques was independent of hsp70 (Pearson correlation, r =
0.11; Bartlett χ2 analysis, P = .71). Within the ulcerated plaque group, there was a correlation between degree of steno-
sis and high HDJ-2 mRNA expression (r = 0.896, P = .016). However, there was no correlation between degree of
stenosis and high HDJ-2 mRNA expression within the nonulcerated plaque group (r = 0.530, P = .076) or within the
entire group of patients (r = 0.0085, P = .97).
Conclusion: These results demonstrate that expression of HDJ-2 is significantly increased in atherosclerotic carotid
artery plaques as compared with hsp60 and hsp70 and correlates with luminal stenosis in ulcerated atherosclerotic
carotid artery plaques. (J Vasc Surg 2001;33:1065-71.)
study shows a significant correlation between increased in
situ HDJ-2 expression and plaque ulceration plus degree
of luminal stenosis associated with the lesion. Therefore,
the data presented herein indicate that increased in situ
HDJ-2 expression plays an important role in the patho-
genesis of advance atherosclerotic plaques.
METHODS
Patients and tissues. Twenty-six atherosclerotic
carotid artery plaques were obtained from patients under-
going carotid endarterectomy as approved by the Human
Studies Committee at Washington University School of
Medicine. As controls, 17 nonatherosclerotic arteries of
similar size were obtained from cadaveric organ transplant
donors (11 carotid arteries, 3 internal iliac arteries, and 3
femoral arteries). The size of the specimens varied
between 1 and 2 g of tissue for both patients and control
subjects. Necrotic lipid core and debris were removed
from the atherosclerotic carotid artery plaques by means
of microscopic dissection at 4°C. The adventitia and the
media layer of the nonatherosclerotic intimas were also
removed by means of microscopic dissection at 4°C, to
match the processing of the atherosclerotic carotid artery
plaques. Each specimen was then cut into two pieces. One
piece was fixed in 10% buffered formalin for paraffin
embedding, and the other was immediately frozen in liq-
uid nitrogen for RNA isolation. The degree of luminal
stenosis associated with the atherosclerotic carotid artery
plaque was measured before operation in all patients by
angiography by means of the following formula: 100 × [1
– (MML/DL)] in which MML is the smallest luminal
diameter at the stenotic site and DL is the luminal diame-
ter distal to MML at the site in which the arterial walls
become parallel. The presence of ulceration in the athero-
sclerotic carotid artery plaque was determined by histo-
logic analysis, as well as angiography as described above.
Reverse transcription-polymerase chain reaction.
Tissue samples were homogenized at –20°C with a Tissue
Tearer (Biospec Products, Bartesville, Okla), and total
RNA was isolated by use of Trizol (Gibco BRL,
Gaithersburg, Md). All RNA samples were treated for 15
minutes at 37°C with RNase-free RQ1 DNase (Promega,
Madison, Wis), then examined by 1% agarose elec-
trophoresis to verify RNA integrity. Subsequently, reverse
transcription (RT) was performed with total RNA 5 µg in
RT buffer 20 µL (oligo dT 1 mg/mL; random pDN6
primer 1 mg/mL; Tris pH 7.6 1 mol/L; potassium chlo-
ride 1 mol/L; magnesium chloride 250 mmol/L;
deoxynucleotides triphosphate, 5 mmol/L each; ditio-
threitol 0.1 mol/L; RNasin, 100 units, and actinomycin
D, 0.1 µg/mL) with Moloney murine leukemia virus
reverse transcriptase at 37°C for 2 hours. After RT the
reaction was heated at 95°C for 5 minutes and used as a
template for polymerase chain reaction (PCR). Varying
concentrations of cDNA were used as the template for
PCR (1 µL of undiluted, 1:5, 1:10, and 1:20 dilutions) to
determine the level of HDJ-2, hsp60, hsp70, and β-actin
mRNA expression. The cDNA (1 µL) was amplified for 30
cycles with a Coy thermal cycler (Laboratory Products
Inc, Ann Arbor, Mich) with these parameters: denatura-
tion at 95°C for 60 seconds; annealing at 58°C (for β-
actin, HDJ-2, and hsp60) or at 52°C (for hsp70) for 30
seconds; and extension at 72°C for 60 seconds. At the end
of the amplification, 30 µL of each sample was analyzed
on 1% agarose gel (FisherBiotech, Fair Lawn, NJ).
Southern blot analysis. At the end of the PCR, 30
µL of each sample was analyzed by Southern blot analysis
with Genescreen plus membrane (NEN/Dupont, Boston,
Mass). The Southern blots were prehybridized according
to the manufacturer’s directions and hybridized with a
phosphorus 32–labeled internal probe specific for each of
the genes. The membranes were washed under stringent
conditions according to the manufacturer’s directions and
exposed to XR5 film (Eastman Kodak Co, Rochester, NY)
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Table I. Primer pairs and oligonucleotide probes used for RT-PCR and Southern blot analysis
HDJ-2 (1438 bp mRNA) (Genbank reference NID g306713; accession no. L08069)
Forward primer: 5´-CCGCACCGGCAGTAGAAGATGGTGAAAGAA-3´ (bp 65-94)
Reverse primer: 5´-TCTCTCGAACTATCTTCCTTCCGTTGCAGC-3´ (bp 666-695)
cDNA probe: 5´-AAAGAAAAGGGAATTATATGAC-3´ (bp 256-277)
Expected amplification product: 630 bp
Hsp70 (1180 bp mRNA) (Genbank reference NID g188491; accession no. M59829 M34268)
Forward primer: 5´-ACCATCACCAATGACAAG-3´ (bp 2469-2486)
Reverse primer: 5´-TGTGATGATAGGGTTACA-3´ (bp 2772-2789)
cDNA probe: 5´-AATGCCTTAGAATCCTAT-3´ (bp 2583-2600)
Expected amplification product: 320 bp
Hsp60 (2202 bp mRNA) (Genbank reference NID g184411; accession no. M34664)
Forward primer: 5´-GGTTATGATGCTATGGCT-3´ (bp 1528-1545)
Reverse primer: 5´-GCAGTACACTGGTACATG-3´ (bp 2007-2024)
cDNA probe: 5´-AACTGTGACAGGAAGCCC-3´ (bp 1778-1795)
Expected amplification product: 496 bp
β-actin (1138 bp mRNA) (Genbank reference NID g2116654; accession no. AB004047)
Forward primer: 5´-TGACGGGGTCACCCACACTGTGCCCATCTA-3´ (bp 478-507)
Reverse primer: 5´-CTAGAAGCATTTGCGGTGGACGATGGAGGG-3´ (bp 1109-1138)
cDNA probe: 5´-GGCTGGCCGGGACCTGACTGACTACCTCAT-3´ (bp 550-579)
Expected amplification product: 660 bp
overnight at –70°C. The PCR primers and oligonu-
cleotide probes used in this study are shown in Table I.
Autoradiograms of the Southern blots were analyzed by
use of a laser densitometer (Pharmacia LKB, Piscataway,
NJ). Data are expressed as arbitrary mRNA units repre-
senting the densitometry values obtained for HDJ-2,
hsp60, and hsp70, corrected for the dilution factor, and
then divided by the densitometry values obtained for the
corresponding β-actin values.
Immunohistochemistry. Paraffin-embedded tissues
were sectioned at 5 µm, attached to glass slides, and
deparaffinized as described.8 Endogenous peroxidase
activity was blocked by incubating the slides in 0.3% H2O2
for 30 minutes at room temperature. An affinity-purified
mouse immunoglobulin G (IgG) monoclonal antibody
raised against human HDJ-2 was used as the primary anti-
body at 1:100 and 1:500 dilutions.9 An isotype-matched
IgG monoclonal antibody (MOPC; Cappel, Durham,
NC) was used as negative control in all experiments at
similar concentrations. A biotinylated goat-antimouse IgG
(Cappel) (1:200 dilution) was then used as a secondary
antibody. The immune complexes were detected by use of
a Vectastain ABC kit (Vector Laboratory, Burlingame,
Calif). Slides were counterstained with Harris hematoxylin
(Sigma Chemical Co, St Louis, Mo).
Statistical analysis. Statistical analysis of the data was
performed by use of the Mann-Whitney statistical analysis
(P < .05), the Pearson correlation analysis, and the Bartlett
χ2 analysis (P < .05).
RESULTS
HDJ-2 expression is upregulated in atherosclerotic
carotid artery plaques. The initial goal of the study
described herein was to determine whether HDJ-2 expres-
sion is upregulated in atherosclerotic carotid artery plaques
in situ. RT-PCR was performed with hsp-specific primers
and total RNA isolated from individual carotid endarterec-
tomy specimens or normal arterial tissues to determine the
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amount of hsp mRNA transcripts. Fig 1 shows the RT-
PCR products derived from HDJ-2 and β-actin (internal
control) mRNAs isolated from five atherosclerotic carotid
artery plaques and five nonatherosclerotic intimas. These
results demonstrate that HDJ-2 expression is significantly
increased in atherosclerotic carotid artery plaques when
Fig 1. Southern blot analysis of HDJ-2 and β-actin RT-PCR products of representative atherosclerotic carotid artery plaques and
nonatherosclerotic intimas. Sizes of HDJ-2 and β-actin bands are 630 base pairs and 660 base pairs, respectively. Briefly, tissue samples
were homogenized and total RNA was isolated. Subsequently, RT was performed with M-MLV reverse transcriptase. After RT, reaction
was used as template for PCR. cDNA was amplified with specific primer pairs for HDJ-2 and β-actin. At end of PCR, each sample was
analyzed by Southern blot with 32P-labeled internal probe specific for each of genes. Membranes were then exposed to XR5 film. PCR
primers and oligonucleotide probes used in this study are shown in Table I.
Table II. HDJ-2 expression in atherosclerotic carotid
artery plaque
Atherosclerotic carotid Nonatherosclerotic
artery plaque intima
1.60 0.41
1.27 0.35
1.53 0.14
0.90 0.15
0.88 0.21
14.35 0.41
9.86 0.37
25.83 0.10
8.07 0.08
10.37 0.07
12.61 0.04
15.66 0.04
28.63 0.03
18.10 0.03
8.70 0.02
3.80 0.01
3.40 0.01
1.90
1.40
1.20
1.10
0.97
0.87
0.67
0.65
0.62
Mean ± SEM 6.73 ± 1.59 0.14 ± 0.04
Mann-Whitney analysis: P = .001.
compared with nonatherosclerotic intimas. RT-PCR prod-
ucts were subjected to Southern blot analysis with specific
internal oligonucleotide probes for HDJ-2 and β-actin to
establish the specificity of the PCR reactions. The results
shown in Table II indicate that, in spite of some degree of
variability, the HDJ-2 mRNA expression in atherosclerotic
carotid artery plaques is significantly upregulated when
compared with nonatherosclerotic intimas (mean ± SEM
6.73 ± 1.59 vs 0.14 ± 0.04, respectively; P = .001). The
expression of hsp70 and hsp60 mRNAs in atherosclerotic
carotid artery plaques was also evaluated by means of RT-
PCR and Southern blotting analysis. As shown in Table
III, the expression of hsp70 mRNA is also significantly
increased in atherosclerotic carotid artery plaques when
compared with nonatherosclerotic intimas (mean ± SEM
9.51 ± 0.94 vs 3.72 ± 0.78, respectively; P = .002). In con-
trast, the expression of hsp60 mRNA is not significantly
different in arterosclerotic carotid artery plaques when
compared with nonatherosclerotic intimas (mean ± SEM:
21.05 ± 0.91 vs 20.61 ± 0.78, P = .647).
HDJ-2 and hsp70 are independently expressed in
atherosclerotic carotid artery plaques. To determine
whether the HDJ-2 mRNA expression correlated with
that of hsp70 mRNA expression in the atherosclerotic
carotid artery plaques examined, we reanalyzed the level
of hsp70 mRNA expression in parallel with the level of
HDJ-2 mRNA expression in situ. Table IV shows the val-
ues for all the samples ranging from 0.88 to 28.63 for
HDJ-2 and 3.35 to 18.49 for hsp70. In addition, the
results shown in Table IV indicate that the expression of
HDJ-2 and hsp70 is not correlated with each other in ath-
erosclerotic carotid artery plaques (r = 0.112, P = .715).
HDJ-2 expression is correlated with plaque ulcer-
ation plus degree of stenosis, but not with degree of
stenosis alone. To determine whether HDJ-2 expression
correlated with a particular clinical stage of the disease, we
compared the level of HDJ-2 mRNA expression in indi-
vidual carotid endarterectomy specimens with the severity
of each atherosclerotic lesion and the clinical status of each
patient. Specimens with different levels of HDJ-2 mRNA
expression were analyzed in terms of the degree of carotid
artery stenosis, the presence of plaque ulceration, as well
as the patients’ history of diabetes, hypertension, and
tobacco use. As shown in Table V, the HDJ-2 mRNA
expression was significantly higher in ulcerated plaques
(patients 13-18) compared with nonulcerated plaques
(patients 1-12) (mean ± SEM: 18.54 ± 2.97 vs 2.57 ±
0.90; P = .0007). Within the ulcerated plaque group
(patients 13-18), there was a correlation between degree
of stenosis and HDJ-2 mRNA expression (r = 0.896, P =
.016). However, there was no correlation between degree
of stenosis and HDJ-2 mRNA expression within the
nonulcerated plaque group (patients 1-12) (r = 0.530, 
P = .076) or within the entire group of patients (r =
0.0085, P = .97). Similar analyses demonstrated a lack of
correlation between the levels of hsp70 mRNA expression
and plaque ulceration (mean ± SEM: 9.1 ± 1.89 for nonul-
cerated plaques vs 11.49 ± 1.84 for ulcerated plaques; P =
.38) or the degree of stenosis (r = –0.07, P = .82).
Localization of the HDJ-2 protein expression in the
atherosclerotic carotid artery plaque. The microscopic
features of the atherosclerotic carotid artery plaques
included an endothelial-lined fibrous cap containing
smooth muscle cells, macrophage-derived foam cells, lym-
phocytes, collagen, elastin, and proteoglycans. In addition,
the atherosclerotic carotid artery plaques included a
necrotic lipid core containing cell debris, cholesterol crys-
tals, and foam cells; and part of the media layer normally
removed during endarterectomy procedures (data not
shown). Immunohistochemical analysis with the anti–HDJ-
2 monoclonal antibody was used to determine the tissue
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Table III. hsp70 and hsp60 expression in atherosclerotic
carotid artery plaque
hsp70 hsp60
ACP NAI ACP NAI
6.77 5.90 18.79 19.67
11.20 5.55 13.08 16.44
9.95 1.92 13.09 29.74
15.41 3.49 14.05 21.04
15.51 5.88 25.72 21.86
3.65 2.28 22.43 22.26
8.94 1.02 17.44 13.29
9.10 19.14
11.56 19.13
3.35 30.64
8.03 17.97
10.15 23.48
10.27 25.17
9.22 18.49
37.07
Mean ± 9.51 ± 3.72 ± 21.05 ± 20.61 ±
SEM 0.94* 0.78* 0.91† 0.78†
ACP, Atherosclerotic carotid artery plaque; NAI, nonatherosclerotic intima.
*Mann-Whitney analysis: P = .002.
†Mann-Whitney analysis: P = .647.
Table IV. HDJ-2 and hsp70 are independently expressed
in atherosclerotic carotid artery plaque
Patient HDJ-2 hsp70
1 0.88 3.65
2 0.90 15.51
3 1.27 9.95
4 1.53 15.41
5 1.60 6.77
6 8.07 3.35
7 9.86 9.10
8 10.37 8.03
9 12.61 10.15
10 14.35 8.94
11 15.66 18.49
12 25.83 11.56
13 28.63 9.22
Pearson correlation analysis: r = 0.112.
Bartlett χ2 analysis: P = .715.
localization of the HDJ-2 protein in carotid endarterec-
tomy specimens.9 As shown in Fig 2, A and B, high levels
of the HDJ-2 protein were detected in the atherosclerotic
carotid artery plaques. Immunoreactive HDJ-2 protein was
localized to macrophage-derived foam cells (Fig 2, A), sur-
face endothelial cells (Fig 2, B), and vascular smooth muscle-
like myointimal cells (Fig 2, B). In contrast, no significant
levels of the HJD-2 protein were detected in the nonathero-
sclerotic intimas (Fig 2, C and D). No significant reactivity
was detected with the MOPC monoclonal antibody (nega-
tive control) in either the atherosclerotic carotid artery
plaques or the nonatherosclerotic intimas (data not shown).
DISCUSSION
Hsps were first described as proteins produced by
organisms in response to heat stress. In addition to their
rapid induction by heat stress, it has recently been recog-
nized that these proteins may also be upregulated by expo-
sure to oxygen radicals,10 cytokines,11 hemodynamic
stress,12 ischemia,13 surgical stress,14 and viral infection.15
In addition to their role in protecting the organism from
stress, hsps have also been found to be involved in the
pathogenesis of autoimmune diseases such as adjuvant-
induced arthritis in rats,16 diabetes mellitus in the
nonobese diabetic mouse,17 rheumatoid arthritis in
human beings,18 and systemic sclerosis in human beings.19
Traditionally, atherosclerosis has been thought of as a
lipid disorder. However, there is increasing evidence sug-
JOURNAL OF VASCULAR SURGERY
Volume 33, Number 5 Nguyen et al 1069
gesting that atherosclerosis may have an autoimmune
component against hsps. For example, it has been shown
that normocholesterolemic rabbits immunized with
mycobacterial hsp65, which has a high homology with
mammalian hsp60, developed atherosclerotic lesions.20
In addition, hsp65-reactive T cells were also isolated
from these lesions.21 Hsp60 expression was also found in
human atherosclerotic lesions by immunohistochemical
analysis.22 Moreover, hsp60 has been found to be coex-
pressed with ICAM-1 and to increase the adhesion of mono-
cytes and T cells to aortic endothelium.3 Several studies have
confirmed the presence of a high number of activated CD4+
and CD8+ T cells in human atherosclerotic plaques.23-28
Taken together, these results indicate that the hsp60 expres-
sion plays an important role in the immunopathogenesis of
the atherosclerotic lesion.1 However, hsp60 expression may
not be the only factor in the immunopathogenesis of the dis-
ease since hsp60 is also expressed in normal arterial tis-
sues.6,7,20-22 Moreover, Xu et al22 also found that a large
population of the T cells infiltrating the atherosclerotic
lesion did not respond to hsp60. 
In contrast to hsp60, we report herein that HDJ-2
expression is significantly elevated in arteriosclerotic
carotid artery plaques when compared with nonathero-
sclerotic intimas (Table II). Perhaps more important, we
also found a significant correlation between HDJ-
2–expression and plaque ulceration (Table V). These
results suggest that HDJ-2 may play an important role in
Table V. HDJ-2/hsp70 expression and patient’s clinical characteristics
Diabetes Tobacco Degree of Plaque
Patient HDJ-2 hsp70 Hypertension mellitus usage stenosis ulceration
1 0.62 NA + – + 90% –
2 0.65 NA + – + 80% –
3 0.67 NA + – + 90% –
4 0.88 3.65 + – – 70% –
5 0.90 15.51 + – + 80% –
6 0.97 NA – – – 95% –
7 1.27 9.95 – + + 80% –
8 1.53 15.41 + – + 90% –
9 1.60 6.77 – – + 85% –
10 3.80 NA + – + 90% –
11 8.07 3.35 + – + 90% –
12 9.86 9.10 + + + 99% –
13 10.37 8.03 + – + 60% +
14 12.61 10.15 + – + 75% +
15 15.66 18.49 + – + 70% +
16 18.10 NA + – – 85% +
17 25.83 11.56 + – + 85% +
18 28.63 9.22 + – + 99% +
Comparison of HDJ-2 expression between no plaque ulceration (patients 1-12, mean ± SEM: 2.57 ± 0.90) and plaque ulceration (patients 13-18, mean ±
SEM: 18.54 ± 2.97): Mann-Whitney analysis, P = .0007.
Comparison of hsp70 expression between no plaque ulceration (patients 1-12, mean ± SEM 9.1 ± 1.89) and plaque ulceration (patients 13-18, mean ±
SEM: 11.49 ± 1.84): Mann-Whitney analysis, P = .38.
Significant correlation between degree of stenosis and HDJ-2 expression in plaque ulceration (patients 13-18): Pearson correlation coefficient: r = 0.896,
Bartlett χ2 P = .016.
No correlation between degree of stenosis and HDJ-2 expression in no plaque ulceration (patients 1-12): Pearson correlation coefficient: r = 0.530, Bartlett
χ2 P = .076.
No correlation between degree of stenosis and HDJ-2 expression in all patients: Pearson correlation coefficient: r = 0.0085, Bartlett χ2 P = .97.
No correlation between degree of stenosis and hsp70 expression in all patients: Pearson correlation coefficient: r = –0.07, Bartlett χ2 P = .87.
the immunopathogenesis of the atherosclerotic lesion.
HDJ-2–reactive T cells must be demonstrated in the ather-
osclerotic lesion to prove this hypothesis. Current studies in
our laboratory are aimed toward this goal. Up to this date,
this is the first study demonstrating increased expression of
HDJ-2 in atherosclerotic carotid artery plaques. The
immunogenicity of HDJ-2 has been demonstrated by our
previous studies in renal and lung transplantation.6,7 The
expression of this hsp has been shown to be increased in kid-
ney6 and lung7 allografts undergoing rejection. Thus, HDJ-
2 may also be responsible for T-cell activation during the
immunopathogenesis of the atherosclerotic lesion.
Hsp70 expression was also found in this study to be
significantly elevated in atherosclerotic carotid artery
plaques when compared with nonatherosclerotic intimas
(Table III), a result that is consistent with previous
reports.29,30 However, hsp70 is thought to play a protec-
tive rather than a causative role in atherosclerosis. Hsp70
was found to be differentially distributed in atherosclero-
sis and insufficient hsp70 accumulation in arterial smooth
muscle cells resulted in cell necrosis.29
Hsps have also been shown to play a role in humoral
response in atherogenesis. Anti-hsp65 antibodies have
been found to be significantly elevated in subjects with
carotid atherosclerosis, independent of other risk factors.4
Complement-fixing autoantibodies to hsp60 were also
shown to induce endothelial cytotoxicity.31 Whether the
antibody response to hsps represents a primary or sec-
ondary event in immunopathogenesis of the atheroscle-
rotic lesion is still unknown. Because HDJ-2 expression is
significantly upregulated in the atherosclerotic carotid
artery plaques, current studies in our laboratory are aimed
to screen for the development of anti–HDJ-2 antibodies
in patients with atherosclerotic disease.
The results of this study suggest a possible role for
HDJ-2 in the development or progression of atheroscle-
rotic carotid artery plaques. Further studies are needed
to elucidate the mechanisms by which HDJ-2 might par-
ticipate in this process. HDJ-2 expression showed a sig-
nificant correlation with the degree of luminal stenosis
in ulcerated atherosclerotic carotid artery plaques.
Therefore, understanding these mechanisms may pro-
vide new insights into the pathologic condition of ath-
erosclerosis and potentially lead to new strategies for
therapeutic intervention. 
We thank Dr Richard B. Schuessler for statistical
analysis of the data, Drs Nancy J. Poindexter and Bashoo
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Fig 2. Localization of HDJ-2 protein expression in atherosclerotic carotid artery plaque. Immunohistochemical staining of atheroscle-
rotic carotid artery plaques (A and B) and nonatherosclerotic intimas (C and D) was performed with anti–HDJ-2 mouse monoclonal
antibody. Immunoreactive HDJ-2 protein was localized to macrophage-derived foam cells (A, arrow), surface endothelial cells (B, right
arrow), and vascular smooth muscle-like myointimal cells (B, left arrow). Asterisk denotes lumen of vessels. Briefly, paraffin-embedded
tissues were sectioned, attached to glass slides, and deparaffinized. Endogenous peroxidase activity was blocked by incubating the slides
in H2O2. Monoclonal antibody raised against human HDJ-2 was used as primary antibody. Biotinylated goat-anti-mouse IgG was used
as secondary antibody. Immune complexes were detected with Vectastain ABC kit (Vector Laboratory). Slides were counterstained with
Harris hematoxylin (Sigma).
Naziruddin for critical review of the manuscript, and Mrs
Billie Glasscock for secretarial assistance.
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